March 22, 2022
Life Sciences
  • Pfizer Inc. said it struck a deal to sell up to 4 million courses of its COVID-19 antiviral pill at a “not-for-profit price” to the United Nations Children’s Fund, which will distribute the treatment to 95 lower-income countries. The drugmaker will begin shipping pills in April and expects to produce 120 million courses of the treatment by the end of the year. (Article here)